AB.PA
AB Science SA
Price:  
1.21 
EUR
Volume:  
23,133.00
France | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AB.PA Relative Valuation

-302.5%
Upside

As of 2026-03-20, the Relative Valuation of AB Science SA (AB.PA) is (2.46) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 1.21 EUR, the upside of AB Science SA based on Relative Valuation is -302.5%.

The range of the Relative Valuation is (2.38) - (2.23) EUR.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 14.1x - 17.3x 16.0x
Forward P/E multiples 18.5x - 27.1x 22.0x
Fair Price (2.38) - (2.23) (2.46)
Upside -296.2% - -284.1% -302.5%
1.21 EUR
Stock Price
(2.46) EUR
Fair Price

AB.PA Relative Valuation - Historical P/E Data

Date P/E
2026-03-13 -9.46
2026-03-12 -9.66
2026-03-11 -9.86
2026-03-10 -10.11
2026-03-09 -9.72
2026-03-06 -9.98
2026-03-05 -10.04
2026-03-04 -10.11
2026-03-03 -9.64
2026-03-02 -10.08
2026-02-27 -10.48
2026-02-26 -10.54
2026-02-25 -10.51
2026-02-24 -10.45
2026-02-23 -10.31
2026-02-20 -10.37
2026-02-19 -10.23
2026-02-18 -9.95
2026-02-17 -9.95
2026-02-16 -9.89
2026-02-13 -10.28
2026-02-12 -10.31
2026-02-11 -10.39
2026-02-10 -10.74
2026-02-09 -10.62
2026-02-06 -10.70
2026-02-05 -10.63
2026-02-04 -10.77
2026-02-03 -10.80
2026-02-02 -10.93
2026-01-30 -10.88
2026-01-29 -10.77
2026-01-28 -10.93
2026-01-27 -11.04
2026-01-26 -10.99
2026-01-23 -11.13
2026-01-22 -11.13
2026-01-21 -10.63
2026-01-20 -10.66
2026-01-19 -10.70
2026-01-16 -10.94
2026-01-15 -10.93
2026-01-14 -10.96
2026-01-13 -10.93
2026-01-12 -11.11
2026-01-09 -11.47
2026-01-08 -11.38
2026-01-07 -10.91
2026-01-06 -10.80
2026-01-05 -10.97